Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus
Polosa, P.; Mughini, L.
La Clinica Terapeutica 84(2): 135-140
1978
ISSN/ISBN: 0009-9074 PMID: 648096 Document Number: 130629
Document emailed within 1 workday
Related Documents
Mailhot, J. 1993: Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study Clinical Therapeutics 15(6): 1060-1068Igaki, A.; Kobayashi, K.; Kimura, M.; Sakoguchi, T.; Hashimoto, M.; Matsuoka, A. 1986: High-performance liquid chromatographic determination of gliclazide (oral hypoglycemic agent) in serum--trial of sensitive fluorometric determination Rinsho Byori. Japanese Journal of Clinical Pathology 34(2): 201-205
Kosachunhanun, N.; Benjasuratwong, Y.; Mongkolsomlit, S.; Rawdaree, P.; Plengvidhya, N.; Leelawatana, R.; Bunnag, P.; Pratipanawatr, T.; Krittiyawong, S.; Suwanwalaikorn, S.; Deerochanawong, C.; Chetthakul, T.; Ngarmukos, C.; Komoltri, C. 2006: Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage Journal of the Medical Association of Thailand 89(Suppl 1): S66-S71
Chugh, S.N.; Dhawan, R.; Kishore, K.; Sharma, A.; Chugh, K. 2001: Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study Journal of the Association of Physicians of India 49: 803-807
Dukhochenko, I.N.; Garbuzova, L.M.; Linchevskiĭ, G.L.; Soroka, I.A. 1977: Atypical hypoglycemic states in diabetes mellitus in children Pediatriia Akusherstvo i Ginekologiia 2: 5-7
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Imamura, Y.; Kimachi, K.; Nagase, S.; Otagiri, M. 1990: Hypoglycemic action and disposition of gliclazide in normal and analbuminemic rats Archives Internationales de Pharmacodynamie et de Therapie 304: 44-54
Lubetzki, J. 1976: Hypoglycemic medications and vascular complications of diabetes mellitus. Current controversy La Revue du Praticien 26(45): 3173-3183
Kunoh, Y.; Iguchi, A.; Gotoh, M.; Nomura, T.; Shibata, M.; Sakamoto, N. 1986: Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 280(2): 302-313
Kunoh, Y.; Ogawa, H.; Nagasaka, M.; Asai, H.; Iguchi, A.; Niki, A.; Sakamoto, N. 1989: Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 298: 276-287
Frati-Munari, A.C.; Del Valle-Martínez, L.M.; Ariza-Andraca, C.R.; Islas-Andrade, S.; Chávez-Negrete, A. 1989: Hypoglycemic action of different doses of nopal (Opuntia streptacantha Lemaire) in patients with type Ii diabetes mellitus Archivos de Investigacion Medica 20(2): 197-201
Toyoshima, H.; Hanafusa, T.; Nonaka, K.; Tarui, S. 1981: Heterogenous dysfunctions of pancreatic a and B cells in diabetes mellitus: a study by consecutive hyper-and hypoglycemic stimulation Medical Journal of Osaka University 31(3-4): 93-100
Lirussi, F.; Beccarello, A.; Zanette, G.; De Monte, A.; Donadon, V.; Velussi, M.; Crepaldi, G. 2002: Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent Diabetes Nutrition and Metabolism 15(4): 222-231
Miranda, V.P.; Rodrigues, M.J.O.; Gonçalves, F.R.; Nunes, J.é P.L. 2009: Effects of hypoglycemic agents on mortality and major cardiovascular outcomes in patients with type 2 diabetes mellitus: a narrative review [88 Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(10): 1099-1119
Castro-Ríos, Aélica.; Reyes-Morales, H.; Pérez-Cuevas, R. 2008: An evaluation of a continuing medical education program for primary care services in the prescription of hypoglycemic agents in diabetes mellitus type 2 Salud Publica de Mexico 50 Suppl. 4: S445-S452
Knudtzon, J.; Meen, H.D.; Baevre, H.; Søvik, O. 1983: Children and adolescents with diabetes mellitus. Understanding diabetes mellitus in relation to treatment and control Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(5): 511-515
Hazard, J. 1976: Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use La Nouvelle Presse Medicale 5(14): 903-905
Zhukovskiĭ, M.A.; Belikhova, E.L.; Volkova, T.N.; Kireeva, V.S. 1971: Discussion of the nutrition of children with diabetes mellitus, (concerning the review by V. G. Baurnov et al of the book by M. A. Zhukovsky et al, The Therapeutic Nutrition of Children with Diabetes Mellitus) Pediatriia 50(7): 68-71
Thorsby, P.; Kilhovd, B.; Sletmo, R.; Martinsen, S.; Birkeland, K.I. 2000: Hypoglycemic treatment of type 2 diabetes Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2434-2440
Sokup, A.; Swiatkowski, M. 2000: New hypoglycemic drugs in treatment of diabetes type 2 Przeglad Lekarski 57(6): 349-352